Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Return to Sender who wrote (200)	2/6/2000 11:58:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1142

Gosh, I'd not have sounded so critical if I'd known it was your personal website, careless of me. Well I guess a place to start is the lists here on SI--but they are way out of date...for example Genomic Database: techstocks.com pathetic, where are Sequenom, Celera, Hyseq, Curagen, Gene Logic, Genset--just for starters. Maybe there is nothing really to work with here on SI. So, how about catagories by science? Sea Otter threw out the biggest sector, monoclonal antibodies. And how about chemistry, or chemical genetics, signal transduction? Gene Therapy of course, with subcatagories by vector or target disease? Antisense. Neurobiological. This is too tough a job for me by myself to tackle--and for what purpose are whe characterizing them? The biotech guys here on SI have in the past put them into baskets based on how they were being valued at the time (cheap a few months ago) --many portfolios were set up last year when nobody loved biotech, these baskets have performed spectacularly. The exercise is too big for me, I could try chemical genetics --this could take a couple weeks, but I can give it a go.